Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2016
NCT02786329
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor | Regional Institute of Gastroenterology and Hepatology "Prof. Dr. O. Fodor" | Regional Institute of Gastroenterology and Hepatology Prof. Dr. O. Fodor

Active Ingredients

Drugs in Phase 2 Trials (2)

lidocaine (xylocaine) (3 trials)

ropivacaine (naropin) (1 trial)

Drugs in Phase 1 Trials (3)

fentanyl (Innovar) (1 trial)

propofol (diprivan) (2 trials)

sevoflurane (ultane) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 1)

Recurrence (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 5